Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Indian J Pediatr ; 85(6): 426-432, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29396775

ABSTRACT

OBJECTIVE: To detect the most effective biomarker to confirm ventilator associated pneumonia (VAP). METHODS: Fifty patients with VAP suspicious diagnosis and 30 healthy patients were recruited. Suspicion of VAP was established if patients met the modified CPIS score ≥ 6 points. The confirmation of VAP was defined by the quantitative culture of nonbronchoscopic bronchoalveolar lavage (BAL) >105 CFU/ml of pathogenic microorganism. Serum samples for determination of C-reactive protein (CRP), procalcitonin (PCT), pentraxin 3 (PTX3), surfactant protein D (SPD) were collected on suspected VAP. RESULTS: Twenty seven of 50 patients were accepted as confirmed VAP group whose nonbronchoscopic BAL cultures were positive and rest of them were accepted as unconfirmed VAP group. PTX3, PCT and SPD levels were significantly higher in confirmed VAP group, (P = 0.021, P = 0.007, P < 0.001 respectively). There were no significant differences in CRP levels between the two groups (P = 0.062). The most sensitive marker for diagnosing VAP was SPD (P < 0.001). Receiver operating characteristic (ROC) curve for modified clinical pulmonary infection score (CPIS) to confirm VAP was evaluated (AUC 0.741 ± 0.07, P < 0.001) and the optimal cutoff value was >7 with a sensitivity of 51.85% and a specificity of 91.3%. SPD levels were significantly higher in Acinetobacter baumannii and Pseudomonas aeruginosa infected patients than culture negative patients (P < 0.001). CONCLUSIONS: The index findings suggest that serum SPD is the most sensitive biomarker in diagnosis of VAP and it can be used as an early and organism specific marker for Acinetobacter baumannii and Pseudomonas aeruginosa.


Subject(s)
Biomarkers/blood , C-Reactive Protein/analysis , Pneumonia, Ventilator-Associated/diagnosis , Pulmonary Surfactant-Associated Protein D/blood , Serum Amyloid P-Component/analysis , Adolescent , Case-Control Studies , Child , Child, Preschool , Female , Humans , Infant , Male , Prospective Studies , Turkey
2.
Turk Neurosurg ; 27(1): 95-98, 2017.
Article in English | MEDLINE | ID: mdl-27560533

ABSTRACT

AIM: Despite different surgical treatment protocols at different centers for spondylodiscitis due to lumbar surgery, there is no consensus on its surgical indications. In this study, we aimed to clarify the steps to be followed in the management and treatment of postoperative spondylodiscitis. MATERIAL AND METHODS: The data of 20 cases with postoperative spondylodiscitis were evaluated. C-reactive protein (CRP) was used for diagnosis and follow-up. According to culture results of the infected material obtained from the operated cases, appropriate antibiotic treatment was initiated. In non-operated cases, parenteral empirical antibiotic treatment was implemented. Surgical treatment was planned for cases with clinical and radiological instability, abscess on imaging and those who were nonrespondent to empirical antibiotic treatment. For the cases that clinically recovered and had normal CRP levels, oral antibiotic treatment was continued after parenteral antibiotic treatment. RESULTS: Of the cases; 13 were male (65%) and 7 were femals (35%). The mean age was 56.3 years (32-74). The most prevalent complaints in referral were waist and leg pain. Except one, all cases had increased CRP levels. All patients had spondylodiscitis on magnetic resonance imaging. Seven had radiological and clinical instability and 3 had epidural abscess. The most commonly growing microorganism in culture was Staphylococcus aureus. Surgical treatment was applied to seven cases and medical treatment to 13 cases. CONCLUSION: In cases with waist pain in the postoperative period, the first potential diagnosis to be considered is spondylodiscitis. Surgical treatment should be implemented for cases resistant to empirical antibiotic treatment, with abscess on imaging, or with lumbar instability.


Subject(s)
Discitis/surgery , Lumbar Vertebrae/surgery , Postoperative Complications/surgery , Aged , Anti-Bacterial Agents/therapeutic use , C-Reactive Protein/metabolism , Discitis/blood , Discitis/diagnosis , Discitis/drug therapy , Epidural Abscess/surgery , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Retrospective Studies , Staphylococcal Infections/drug therapy , Staphylococcal Infections/surgery , Treatment Outcome
3.
Infez Med ; 24(4): 293-298, 2016 12 01.
Article in English | MEDLINE | ID: mdl-28011964

ABSTRACT

Acinetobacter baumannii and Enterobacteriaceae are two pathogens responsible for postneurosurgical meningitis. The aim of this retrospective study was to evaluate the factors that influenced the outcomes in patients with postneurosurgical meningitis caused by A. baumannii and Enterobacteriaceae. Patients with post-surgical meningitis were identified from infection control committee charts between 2007 and 2015. Subjects over 16 years old who had positive cerebral spinal fluid cultures for A. baumannii or Enterobacteriaceae were enrolled in the study. Clinical and laboratory data for 30 patients with A. baumannii meningitis were compared with those of 12 patients with Enterobacteriaceae meningitis. The mean age of patients was 51.9 years and 57.1% were male. Eleven patients had comorbidities, the most common being diabetes mellitus. Most patients were due to intracranial haemorrhage (78.6%). The rate of the patients who received an appropriate antimicrobial therapy was 35.7%, and the crude mortality rate was 64.3%. In univariate analysis, previous antibiotic use, an infection before meningitis and mechanical ventilation had an increased risk of A. baumannii meningitis. Moreover, intrathecal antimicrobial use, inappropriate empirical antimicrobial use, antimicrobial resistance and alanine aminotransferase elevation were significantly higher in patients with A. baumannii meningitis than in those with Enterobacteriaceae meningitis. Antimicrobial use before meningitis (8.84 times) and mechanical ventilation (7.28 times) resulted in an increased risk of A. baumannii meningitis. None of the results affected 30-day mortality. Avoidance of unnecessarily prolonged antimicrobial usage may help to prevent a selection of A. baumannii.


Subject(s)
Acinetobacter Infections/complications , Acinetobacter baumannii/isolation & purification , Anti-Bacterial Agents/therapeutic use , Enterobacteriaceae Infections/complications , Enterobacteriaceae/isolation & purification , Meningitis, Bacterial/drug therapy , Meningitis, Bacterial/microbiology , Adolescent , Adult , Female , Humans , Male , Meningitis, Bacterial/cerebrospinal fluid , Meningitis, Escherichia coli/drug therapy , Meningitis, Escherichia coli/microbiology , Middle Aged , Retrospective Studies , Treatment Outcome
4.
Mikrobiyol Bul ; 50(1): 21-33, 2016 Jan.
Article in Turkish | MEDLINE | ID: mdl-27058326

ABSTRACT

Carbapenems are the choice of treatment in infections caused by multidrug resistant Enterobacteriaceae. In recent years carbapenem-resistant Enterobacteriaceae isolates due to carbapenemases have been increasingly reported worldwide. Multicenter studies on carbapenemases are scarce in Turkey. The aim of this study was to determine the distribution of carbapenemases from different parts of Turkey as a part of the European Survey of Carbapenemase Producing Enterobacteriaceae (EuSCAPE) project. Beginning in November 2013, carbapenem-resistant isolates resistant to at least one of the agents, namely imipenem, meropenem, and ertapenem were sent to the coordinating center. Minimum inhibitory concentrations for these carbapenems were determined by microdilution tests following EUCAST guidelines. Production of carbapenemase was confirmed by combination disk synergy tests. Types of carbapenemases were investigated using specific primers for VIM, IMP; NDM, KPC and OXA-48 genes by multiplex polymerase chain reaction. In a six month period, 155 suspected carbapenemase-positive isolates were sent to the coordinating center of which 21 (13.5%) were E.coli and 134 (86.5%) were K.pneumoniae. Nineteen (90.5%) strains among E.coli and 124 (92.5%) strains among K.pneumoniae were shown to harbour at least one carbapenemase gene by molecular tests, with a total of 92.3% (143/155). Carbapenemases were determined as a single enzyme in 136 strains (OXA-48: 84.6%; NDM: 6.3%; VIM: 2.8%; IMP: 1.4%) and as a combination in seven isolates (OXA-48 + NDM: 2.1%; OXA-48 + VIM: 2.1%; VIM + NDM: 0.7%). KPC was not detected in any of the isolates. According to the microdilution test results, resistance to imipenem, meropenem and ertapenem in OXA-48 isolates were 59.5%, 52.9% and 100%, respectively. The combination disk synergy test was 100% compatible with the molecular test results. As most of the OXA-48 producing isolates were susceptible to meropenem but all were resistant to ertapenem, ertapenem seems to be the most sensitive agent in screening carbapenemases in areas where OXA-48 is prevalent and phenotypic combination tests can be useful in centers where molecular tests are not available.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Carbapenems/pharmacology , Escherichia coli/enzymology , Klebsiella pneumoniae/enzymology , beta-Lactamases/metabolism , Bacterial Proteins/genetics , Drug Resistance, Multiple, Bacterial/genetics , Ertapenem , Escherichia coli/drug effects , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Humans , Imipenem/pharmacology , Klebsiella pneumoniae/drug effects , Meropenem , Microbial Sensitivity Tests , Multiplex Polymerase Chain Reaction , Phenotype , Thienamycins/pharmacology , Turkey , beta-Lactamases/genetics , beta-Lactams/pharmacology
5.
Int J Pediatr Otorhinolaryngol ; 83: 51-6, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26968053

ABSTRACT

INTRODUCTION: Allergic Rhinitis (AR) effects 20-40% of the global population and its prevalance increases. Medical treatment and immunotherapy could be used in AR management. But they are not definitive solution. Medical treatment must be used a long time and has side effects. Immunotherapy cannot be applied to every patient and it also takes a long time. The aim of this study is to evaluate symptomatic and histopathological effects of intranasal infiltrated Botulinum Toxin-A (Btx-A) on an animal model of AR. MATERIAL-METHOD: 15 rabbits were divided into 3 groups as control, disease and treatment. AR was formed in disease and treatment groups by intraperitoneal and intranasal ovalbumine. Allergic symptoms were observed and serum IgE levels were estimated to prove forming of AR. Btx-A was infiltrated in inferior turbinates of rabbits in treatment group. Rabbits were sacrified on 32nd day. Paranasal structures were disected and investigated histopathologically. RESULTS: Serous nasal discharge and sneezing were observed after ovalbumine applying in disease and treatment groups. Serum IgE levels on 21st day were higher than 1st day and this difference was significant statistically in disease and treatment groups. Serous discharge and sneezing decreased after Btx-A infiltration in treatment group. In histopathological examination, there were significant difference between disease and treatment group in terms of some histopathological findings. CONCLUSION: Considering the effect of Btx-A on AR in animal, it can be said that Btx-A can decrease symptoms and reorganize histopathological findings of AR.


Subject(s)
Acetylcholine Release Inhibitors/administration & dosage , Botulinum Toxins, Type A/administration & dosage , Rhinitis, Allergic/drug therapy , Administration, Intranasal , Animals , Disease Models, Animal , Humans , Immunotherapy , Male , Rabbits , Rhinitis, Allergic/pathology
6.
Pak J Med Sci ; 31(5): 1067-72, 2015.
Article in English | MEDLINE | ID: mdl-26648988

ABSTRACT

OBJECTIVE: To determine the clonal relationship of ESBL-producing and quinolone resistant E.coli strains and to investigate the risk factors for infections with these microorganisms. METHODS: A total of 95 ESBL-producing and quinolone resistant E.coli strains isolated from various clinical specimens of inpatients and outpatients in our hospital were included in the study. Risk factors for infections with ESBL-producing E.coli and demographic data of the patients were obtained from hospital records. The rep-PCR method was used for the determination of the genetic relationship of the strains. RESULTS: Of the strains included in the study, 33(34.7%) were isolated from inpatients and 62(65.3%) from outpatients. At least one risk factor has been identified in all patients for infection with ESBL producing E.coli and the mean of the risk factors of patients was 4.2. The most common risk factor was urinary catheter insertion (57.9%). The distribution of the strains in each clone was as fallows: clone A: 9(9.5%), clone B: 10(10.5%), clone C: 38(40%), clone D: 12(12.5%), clone E: 6(6.3%), clone F: 7(7.3%) and clone G 5(5.3%). The clones A, D and C (dominant clone) were isolated from hospital and community acquired infections. Clones E, F and G were identified as nosocomial clones. CONCLUSION: Infections with multidrug resistant bacteria may be related to the hospital although they were isolated from outpatients. Developing a medical record system is vitally important to prevent the occurence and spread of resistant bacterial infections in the community.

7.
Pak J Med Sci ; 31(5): 1136-9, 2015.
Article in English | MEDLINE | ID: mdl-26649001

ABSTRACT

OBJECTIVE: The determination of HCV genotypes and subtypes is very important for the selection of antiviral therapy and epidemiological studies. The aim of this study was to evaluate the performance of Abbott Real Time HCV Genotype II assay in HCV genotyping of HCV infected patients in Kayseri, Turkey. METHODS: One hundred patients with chronic hepatitis C admitted to our hospital were evaluated between June 2012 and December 2012, HCV RNA levels were determined by the COBAS® AmpliPrep/COBAS® TaqMan® 48 HCV test. HCV genotyping was investigated by the Abbott Real Time HCV Genotype II assay. With the exception of genotype 1, subtypes of HCV genotypes could not be determined by Abbott assay. Sequencing analysis was used as the reference method. RESULTS: Genotypes 1, 2, 3 and 4 were observed in 70, 4, 2 and 24 of the 100 patients, respectively, by two methods. The concordance between the two systems to determine HCV major genotypes was 100%. Of 70 patients with genotype 1, 66 showed infection with subtype 1b and 4 with subtype 1a by Abbott Real Time HCV Genotype II assay. Using sequence analysis, 61 showed infection with subtype 1b and 9 with subtype 1a. In determining of HCV genotype 1 subtypes, the difference between the two methods was not statistically significant (P>0.05). HCV genotype 4 and 3 samples were found to be subtype 4d and 3a, respectively, by sequence analysis. There were four patients with genotype 2. Sequence analysis revealed that two of these patients had type 2a and the other two had type 2b. CONCLUSION: The Abbott Real Time HCV Genotype II assay yielded results consistent with sequence analysis. However, further optimization of the Abbott Real Time HCV Genotype II assay for subtype identification of HCV is required.

8.
Pak J Med Sci ; 31(2): 351-4, 2015.
Article in English | MEDLINE | ID: mdl-26101489

ABSTRACT

OBJECTIVE: Early detection of antibiotic susceptibility profile of the isolates has critical importance in terms of immediate beginning of the appropriate treatment and increasing of treatment success, such as meningitis, bacteriemia and sepsis. In the present study, it was aimed to compare the antibiotic susceptibility results of Quicolor (Salubris Inc., Massachusetts, USA) and standard disk diffusion method. METHODS: One hundred twenty three isolates were included in this study (80 Enterobacteriaceae, 15 Staphylococci and 28 nonfermentative Gram-negative bacteria). Antibiotic susceptibility in clinical isolates was evaluated using Mueller-Hinton (MH) agar and Quicolor (ES and NF) agar plates. RESULTS: For Enterobacteriaceae, frequency of total concordance, major error, and minor error between the tests were found as 96.8%, 0.8%, and 2.4%, respectively. For Staphylococci, frequency of total concordance, major error, and minor error among the tests were found as 95.7%, 3.5%, and 0.8%, respectively. For non fermentative bacteria, frequency of total concordance, major error, and minor error among the tests were found as 83.9%, 9.6%, and 6.4%, respectively. CONCLUSIONS: Quicolor media provided reliable susceptibility results in enteric bacteria and Staphylococci. However, further studies including higher number of nonfermentative bacteria are required to determine whether the chromogenic media are appropriate for this group of bacteria.

9.
Turkiye Parazitol Derg ; 35(3): 151-3, 2011.
Article in English | MEDLINE | ID: mdl-22203505

ABSTRACT

OBJECTIVE: Pediculosis capitis is a worldwide public health concern, and today, head lice are seen in all socio-economic levels. The infestation usually occurs by head-to-head contact and children, primarily girls, aged 3-12 years are mostly affected. In the present study a total of 405 pupils (214 boys and 191 girls) from two pre- and primary schools in the Kayseri-Hacilar region were examined for pediculosis capitis during March 2010. METHODS: Lice and/or eggs were detected by visual examination of the children's hair. RESULTS: Out of 405 children, 44 (10.9%) were infested with head lice. There were significant differences between the schools and the gender while no significant differences could be found between infestation and child's age, education of the parents, income of the family, housing type, source of water, and the presence or absence of a bathroom. CONCLUSION: Head lice remain a public health problem and more emphasis should be given to the education of parents regarding their biology and control.


Subject(s)
Lice Infestations/epidemiology , Pediculus , Scalp Dermatoses/epidemiology , Adolescent , Animals , Child , Female , Humans , Male , Prevalence , Scalp Dermatoses/parasitology , Schools , Sex Distribution , Socioeconomic Factors , Turkey/epidemiology
10.
Mikrobiyol Bul ; 45(4): 581-91, 2011 Oct.
Article in Turkish | MEDLINE | ID: mdl-22090288

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) infections are associated with increased cost, mortality and length of hospital stay compared with the other infections. Therefore, controlling the spread of this pathogen by screening patients, personnel and the environment remains as a high priority in infection control programs. The aim of this study was to detect the clonal relationship between nosocomial MRSA strains by using repetitive-sequence-based polymerase chain reaction (rep-PCR) method which has several advantages owing to its speed and ease of use. A total of 100 MRSA stock strains that had been isolated from various clinical samples of hospitalized patients in Erciyes University Medical Faculty Hospitals between September 2008-October 2009, were included in the study. Methicillin resistance of the strains were determined by cefoxitin disc diffusion test according to CLSI guidelines. Rep-PCR (Diversilab, bioMerieux, France) method was performed in the following four steps in order to determine genetic proximity of MRSA strains: (1) Manual DNA extraction (UltraClean Microbial DNA Isolation Kit; MoBio Laboratories, USA), (2) Rep-PCR by using fingerprinting kits in the thermocycler (Diversilab DNA Fingerprinting Kit), (3) Automated microfluidic electrophoresis by bioanalyzer (Diversilab DNA LabChip kit), (4) Analysis and rapid evaluation with the use of web-based DiversiLab software (version 2.1.66). Rep-PCR analysis have shown the presence of a total 11 clones, including 3 major clones [A (4 subtypes), B (2 subtypes) and C (2 subtypes)] and 8 unique clones (DK). Clone A was found to be the dominant type. Seventy-eight percent of the 100 MRSA isolates belonged to clone A (63 were A1; 9 were A2; 4 were A3, 2 were A4), 11% belonged to clone B (10 were B1, 1 was B2), 3% belonged to clone C (2 were C1, 1 was C2), and one of each belonged to the other clones (D, E, F, G, H, I, J, K). Clone A was isolated from 93.3% (14/15) of the samples sent from internal diseases intensive care unit (ICU), from 66.6% (10/15) of the samples sent from infectious diseases ward and 91% (10/11) of hematology-oncology ward samples. All MRSA strains isolated from anesthesiology and newborn ICU were of clone A. The isolation dates of these strains were in proximity. In conclusion, MRSA strains showed clonal dissemination in our hospital, clone A being the predominant one during the study period. Rep-PCR which is a rapid and reliable method, can easily be applied for molecular epidemiological purposes and aid to infection control measures.


Subject(s)
Cross Infection/microbiology , Genotyping Techniques/methods , Methicillin-Resistant Staphylococcus aureus/classification , Polymerase Chain Reaction/methods , Staphylococcal Infections/microbiology , Cross Infection/prevention & control , DNA Fingerprinting , DNA, Bacterial/chemistry , DNA, Bacterial/isolation & purification , Electrophoresis, Microchip , Humans , Methicillin-Resistant Staphylococcus aureus/genetics , Microbial Sensitivity Tests , Repetitive Sequences, Nucleic Acid , Staphylococcal Infections/prevention & control
11.
Turkiye Parazitol Derg ; 35(2): 96-9, 2011.
Article in Turkish | MEDLINE | ID: mdl-21776595

ABSTRACT

OBJECTIVE: Parasitic infections are an important health problem which affect children more than adults. Especially in growth-age children, this leads to problems such as malnutrition, malabsorption, growth retardation and learning disabilities. In this study, 328 students who were investigated in two primary schools between the ages of 6 and 14 in Kayseri-Hacilar region were analyzed for intestinal parasites. METHODS: Stool samples were analyzed by light microscopy for the detection of helminths and protozoon using the native-lugol method. Cellophane tape samples were also analyzed by light microscopy for the detection of Enterobius vermicularis and Taenia spp. RESULTS: At least one or more intestinal parasite species were found in 116 (35.4 %) children. The distribution of parasites which were detected in stool samples was as follows; Blastocystis hominis, 77 (23.5%); Enterobius vermicularis, 35 (10.7%); Giardia intestinalis, 14 (4.3%); Entamoeba coli, 15 (4.6%); Endolimax nana, 6 (1.8%); Hymenolepis nana, 1 (0.3%); Iodamoeba butschlii, 1 (0.3%). CONCLUSION: Parasitic diseases are a major public health problem and we believe that education about personal hygiene, sanitation rules and parasitic diseases is important to overcome this problem.


Subject(s)
Intestinal Diseases, Parasitic/epidemiology , Adolescent , Amoeba/isolation & purification , Animals , Blastocystis hominis/isolation & purification , Child , Endolimax/isolation & purification , Entamoeba/isolation & purification , Enterobius/isolation & purification , Feces/parasitology , Female , Giardia lamblia/isolation & purification , Health Education , Humans , Hymenolepis nana/isolation & purification , Intestinal Diseases, Parasitic/parasitology , Intestinal Diseases, Parasitic/prevention & control , Male , Turkey/epidemiology
12.
J Med Food ; 14(1-2): 128-34, 2011.
Article in English | MEDLINE | ID: mdl-21128826

ABSTRACT

Honeybee products (honey, royal jelly, pollen, and propolis) were evaluated for their ability to inhibit the growth of 40 yeast strains of Candida albicans, Candida glabrata, Candida krusei, and Trichosporon spp. The broth microdilution method was used to assess the antifungal activity of honeybee products against yeasts. Fluconazole was selected as the antifungal control agent. Using the broth microdilution method, minimal inhibitory concentration ranges with regard to all isolates were 5-80% (vol/vol), 0.06-1 µg/mL, 0.002-0.25 µg/mL, 0.006-0.1 µg/mL, and 0.02-96 µg/mL for honey, royal jelly, pollen, propolis, and fluconazole, respectively. The antifungal activities of each product decreased in the following order: propolis >pollen > royal jelly > > honey. This study demonstrated that honeybee products, particularly propolis and pollen, can help to control some fluconazole-resistant fungal strains.


Subject(s)
Antifungal Agents/pharmacology , Bees/chemistry , Candida/drug effects , Fatty Acids/pharmacology , Honey/analysis , Propolis/pharmacology , Trichosporon/drug effects , Animals , Microbial Sensitivity Tests
13.
Med Mycol ; 47(7): 707-12, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19888803

ABSTRACT

Abstract Honey samples from different floral sources were evaluated for their ability to inhibit the growth of 40 yeast strains (Candida albicans, C. krusei, C. glabrata and Trichosoporon spp.). Broth microdilution method (CLSI, M27-A2) was used to assess the activity of the honeys against yeasts at different concentrations ranging from 1.25-80% (v/v). All of the yeast strains tested were inhibited by honeys in this study. Broth microdilution assay revealed that inhibition of growth depends on the type and concentration of honey as well as the test pathogen. Little or no antifungal activity was seen at honey concentrations <2%. Rhododendron and multifloral honeys have generally more inhibitory effect than eucalyptus and orange honeys (P<0.05). Fluconazole-resistant yeast strains were examined for their susceptibility to honeys. This study demonstrated that, in vitro, these honeys had antifungal activity at the high concentration of 80% (v/v) in these fluconazole-resistant strains. Further studies are now required to demonstrate if this antifungal activity has any clinical application.


Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Honey/analysis , Trichosporon/drug effects , Candida/growth & development , Fluconazole/pharmacology , Microbial Sensitivity Tests , Trichosporon/growth & development , Turkey
SELECTION OF CITATIONS
SEARCH DETAIL
...